Jacobs Levy Equity Management
ACRV icon

Jacobs Levy Equity Management’s Acrivon Therapeutics ACRV Stock Holding History

Jacobs Levy Equity Management’s Portfolio ACRV Stock Details ACRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$455K Buy
+382,234
New +$455K ﹤0.01% 896
2024
Q1 		– Sell
-46,072
Closed -$227K – 933
2023
Q4 		$227K Buy
+46,072
New +$227K ﹤0.01% 916